These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17043117)

  • 1. Quinolone resistance in Helicobacter pylori isolates in Germany.
    Glocker E; Stueger HP; Kist M
    Antimicrob Agents Chemother; 2007 Jan; 51(1):346-9. PubMed ID: 17043117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High secondary resistance to quinolones in German Helicobacter pylori clinical isolates.
    Wueppenhorst N; Stueger HP; Kist M; Glocker EO
    J Antimicrob Chemother; 2013 Jul; 68(7):1562-6. PubMed ID: 23463210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.
    Wueppenhorst N; Stueger HP; Kist M; Glocker E
    J Antimicrob Chemother; 2009 Apr; 63(4):648-53. PubMed ID: 19190100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemifloxacin can partially overcome quinolone resistance of H. pylori with gyrA mutation in Taiwan.
    Chang WL; Kao CY; Wu CT; Huang AH; Wu JJ; Yang HB; Cheng HC; Sheu BS
    Helicobacter; 2012 Jun; 17(3):210-5. PubMed ID: 22515359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
    Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
    Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Helicobacter pylori isolates of dyspeptic Nigerian patients.
    Abdulrasheed A; Lawal OO; Abioye-Kuteyi EA; Lamikanra A
    Trop Gastroenterol; 2005; 26(2):85-8. PubMed ID: 16225052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
    Yang JC; Lee PI; Hsueh PR
    Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1369-75. PubMed ID: 20658256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and eradication of a clinical isolate of Helicobacter pylori resistant to five antimicrobials in Germany.
    Wüppenhorst N; Lenze F; Ross M; Kist M
    J Antimicrob Chemother; 2011 Jan; 66(1):222-3. PubMed ID: 21051371
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
    Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
    J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea.
    Hwang TJ; Kim N; Kim HB; Lee BH; Nam RH; Park JH; Lee MK; Park YS; Lee DH; Jung HC; Song IS
    J Clin Gastroenterol; 2010 Sep; 44(8):536-43. PubMed ID: 20179610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period.
    Oleastro M; Cabral J; Ramalho PM; Lemos PS; Paixão E; Benoliel J; Santos A; Lopes AI
    J Antimicrob Chemother; 2011 Oct; 66(10):2308-11. PubMed ID: 21764826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
    McNulty CA; Lasseter G; Shaw I; Nichols T; D'Arcy S; Lawson AJ; Glocker E
    Aliment Pharmacol Ther; 2012 May; 35(10):1221-30. PubMed ID: 22469191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium.
    Bogaerts P; Berhin C; Nizet H; Glupczynski Y
    Helicobacter; 2006 Oct; 11(5):441-5. PubMed ID: 16961806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection.
    Carothers JJ; Bruce MG; Hennessy TW; Bensler M; Morris JM; Reasonover AL; Hurlburt DA; Parkinson AJ; Coleman JM; McMahon BJ
    Clin Infect Dis; 2007 Jan; 44(2):e5-8. PubMed ID: 17173210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic resistance of Helicobacter pylori].
    Wang F; Shen SR; Zhou JD; Xu CX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 32(3):447-50. PubMed ID: 17611323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
    Chung JW; Lee GH; Jeong JY; Lee SM; Jung JH; Choi KD; Song HJ; Jung HY; Kim JH
    J Gastroenterol Hepatol; 2012 Mar; 27(3):493-7. PubMed ID: 21793912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
    Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
    Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan.
    Hirata Y; Ohmae T; Yanai A; Sakitani K; Hayakawa Y; Yoshida S; Sugimoto T; Mitsuno Y; Akanuma M; Yamaji Y; Ogura K; Maeda S; Koike K
    Int J Antimicrob Agents; 2012 Apr; 39(4):352-5. PubMed ID: 22321702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fourth-generation quinolones in the treatment of
    An Y; Wang Y; Wu S; Wang YH; Qian X; Li Z; Fu YJ; Xie Y
    World J Gastroenterol; 2018 Aug; 24(29):3302-3312. PubMed ID: 30090010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of DX-619, a des-F(6)-quinolone, against Helicobacter pylori.
    Takano T; Higuchi W; Kanda H; Yamamoto T
    J Antimicrob Chemother; 2011 Jan; 66(1):220-2. PubMed ID: 21044976
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.